PB1870: COVID - 19 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: HOSPITAL MORALITY PREDICTORS

por Kochneva, O., Baryakh, E., Misyurina, E., Zhelnova, E., Yatskov, K., Polyakov, Y., Kaluzhskaya, K., Chudnova, T., Tolstykh, T., Ivanova, D.
Publicado 2022

P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID-19

por Chudnova, T., Baryakh, E., Polyakov, Y., Tolstykh, T., Kochneva, O., Ivanova, D., Misyurina, E., Yatskov, K., Zhelnova, E., Litvinenko, M., Kaluzhskaya, K.
Publicado 2022

P1599: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AND CONCOMITANT COVID-19 INFECTION

por Polyakov, Y., Kaluzhskaya, K., Baryakh, E., Gemdzhian, E., Misyurina, E., Zhelnova, E., Yatskov, K., Kochneva, O., Andreev, S., Chudnova, T., Ivanova, D., Tolstykh, T.
Publicado 2022

PB1853: IN-HOSPITAL SURVIVAL OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND CONCOMITANT CORONAVIRUS INFECTION DEPENDING ON VARIOUS CLINICAL FACTORS.

por Baryakh, E., Misyurina, E., Zhelnova, E., Yatskov, K., Kochneva, O., Polyakov, Y., Ivanova, D., Kaluzhskaya, K., Tolstykh, T., Chudnova, T., Samsonova, I., Lysenko, M.
Publicado 2022